3Q PREVIEW: As Merck attempts comeback, Biogen touts future blockbuster
This article was originally published in Scrip
Executive Summary
Merck & Co and Biogen Idec kick off another week of quarterly earnings reports for big US companies with both announcing their results on October 28.